Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 25/2/2021
SIETES contiene 93212 citas

 
 
 1 a 20 de 263 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Agarwal A, Ioannidis JPA. PREDIMED trial of Mediterranean diet: retracted, republished, still trusted?. BMJ 2019;364:7 de febrero. [Ref.ID 103032]
2. Cita con resumen
Benetos A, Rossignol P, Cherubini A, Joly L, Grodzicki T, Rajkumar C, Strandberg TE, Petrovic M. Polypharmacy in the aging patient: management of hypertension in octogenarians. JAMA 2015;314:170-80. [Ref.ID 99347]
3.Tiene citas relacionadas Cita con resumen
Cox TM, Drelichman G, Cravo R, Balwani M, Burrow TA, Martins AM, Lukina E, Rosenbloom B, Ross L, Angell J, Puga AC. Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial. Lancet 2015;385:2355-62. [Ref.ID 99290]
4.Tiene citas relacionadas
Hughes DA, Pastores GM. Eliglustat for Gaucher's disease: trippingly on the tongue. Lancet 2015;385:2328-30. [Ref.ID 99287]
5. Cita con resumen
Abraha I, Cherubini A, Cozzolino F, De Florio R, Luchetta ML, Rimland JM, Folletti I, Marchesi M, Germani A, Orso M, Eusebi P, Montedori A. Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study. BMJ 2015;350:h2445. [Ref.ID 99147]
6.Tiene citas relacionadas Cita con resumen
Redberg RF. All placebos are not created equally. JAMA Intern Med 2013;173:1951. [Ref.ID 96596]
7.Tiene citas relacionadas Cita con resumen
Meissner K, Fässler M, Rücker G, Kleijnen J, Hróbjartsson A, Schneider A, Antes G, Linde K. Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA Intern Med 2013;173:1941-51. [Ref.ID 96593]
9. Cita con resumen
Hernán MA, Hernández-Díaz S, Robins JM. Randomized trials analyzed as observational studies. Ann Intern Med 2013;159:560-2. [Ref.ID 96385]
10. Cita con resumen
Anónimo. Making sense of equivalence and non-inferiority trials. Australian Prescriber 2013;36:170-3. [Ref.ID 96321]
11. Cita con resumen
12. Cita con resumen
Bero L. Industry sponsorship and research outcome: a Cochrane review. JAMA Intern Med 2013;173:580-1. [Ref.ID 95262]
13. Cita con resumen
Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD, for the CONSORT PRO Group. Reporting on patient-reported outcomes in randomized trials: The CONSORT PRO extension. JAMA 2013;309:814-22. [Ref.ID 94991]
14.Tiene citas relacionadas Cita con resumen
Myburgh J, Finfer S, Billot L. Hydroxyethyl starch or saline in intensive care. Author/editor response. N Engl J Med 2013;368:775. [Ref.ID 94970]
15.Tiene citas relacionadas Cita con resumen
Raghunathan K, Shaw A. Hydroxyethyl starch or saline in intensive care. N Engl J Med 2013;368:774-5. [Ref.ID 94969]
16.Tiene citas relacionadas Cita con resumen
Guidet B. Hydroxyethyl starch or saline in intensive care. N Engl J Med 2013;368:774. [Ref.ID 94968]
18.Tiene citas relacionadas Cita con resumen
Thornton JG. HRT and cardiovascular events. Press release was misleading. BMJ 2012;345:27. [Ref.ID 94212]
19.Tiene citas relacionadas Cita con resumen
Schierbeck LL, Kober L, Jensen J-EB. HRT and cardiovascular events. Author's reply. BMJ 2012;345:27. [Ref.ID 94211]
20.Tiene citas relacionadas Cita con resumen
McPherson K. HRT and cardiovascular events. Age hypothesis does not stand. BMJ 2012;345:27. [Ref.ID 94210]
Seleccionar todas
 
 1 a 20 de 263 siguiente >>